Guaranteeing quality and safety to our customers is one of the pillars of our growth and expansion.
Our Quality Control department analyzes the raw materials used in the production processes and final products to ensure that all our extracts are effective, safe and meet the safety requirements and standards in the countries to which they are destined.
1
HABOID decision Tree Evaluation
2
Risk category is assigned
3
The relevant series of test is applied
4
Only guaranteed-pure raw material proceeds to production
Thanks to our vertical integration model and an innovative system developed internally to analyze the risks of the raw materials (Hazard Analysis of Botanical Identity), we ensure the botanical authenticity and maintain the traceability of our ingredients through the most rigorous control systems.
Our HABOID (Hazard Analysis of Botanical Identity) method has proven to be key for the industry. The method is based on determining the risk level of each plant, according to its origin. We perform different studies, both microscopic and macroscopic tests, HPTLC and HPLC for those raw materials identified as high-risk.
We rely on technology, the dynamic nature and reliability of all our processes and departments to ensure that the products are correctly identified and that our clients’ consumers have the assurance that they are consuming the products they expect for the benefits they are seeking.
We manufacture under the most relevant quality standards, with the most up-to-date and prestigious certifications for each market, including the following:
Natac Biotech (Hervás): FSSC22000, FAMIQ`s, ISO 14001, Halal, Kosher, GMP pharma and Organic Certificate. Innovaoleo (As Somozas): GMP+, Halal and FSSC22000.
Our Regulatory Department ensures that we comply with all laws and regulations, guaranteeing that our ingredients improve the safety and quality of their end products.
The Regulatory department also provides technical-regulatory advice to clients and prepares the registration dossiers for active substances required by the pharmaceutical industry.